Table 1. Results of VAS and ROM in Three Groups^a.

	Hyaluronidase	Bicarbonate	Lidocaine	P Value
VAS
Pre-treatment	5.6 ± 0.8	5.3 ± 0.8	5.5 ± 1.0	0.42
Immediately after treatment	5.1 ± 0.6	4.0 ± 0.1	3.8 ± 0.6	0.001
2 weeks	2.8 ± 0.9	4.2 ± 0.7	5.3 ± 0.5	0.001
4 weeks	2.5 ± 0.7	4.4 ± 0.9	5.2 ± 0.6	0.001
ROM
Pre-treatment	18.6 ± 5.8	18.8 ± 6.2	18.5 ± 5.6	0.741
Immediately after treatment	19.3 ± 6.8	19.2 ± 5.8	19.5 ± 5.8	0.067
2 weeks	18.1 ± 5.8	18.8 ± 5.8	18.4 ± 5.8	0.77
4 weeks	18.0 ± 5.8	18.4 ± 5.8	18.3 ± 5.8	0.48

Abbreviations: VAS, visual analogue scale; ROM, range of motion

^aHyaluronidase group permanent effect in VAS reduction.